Skip to main content
main-content

Annals of Nuclear Medicine OnlineFirst articles

Open Access 21.11.2022 | Original Article

Dosimetry and efficacy of a tau PET tracer [18F]MK-6240 in Japanese healthy elderly and patients with Alzheimer’s disease

Tau is the primary protein composing neurofibrillary tangles (NFT). Unlike β-amyloid deposition, post-mortem studies have shown that NFT density correlates with neurodegeneration and cognitive impairment [ 1 – 4 ]. Thus, PET imaging agents that …

15.11.2022 | Original Article

Evaluation of standardized uptake value on 131I-6β-iodomethyl-19-norcholesterol scintigraphy for diagnosis of primary aldosteronism and correspondence with adrenal venous sampling

Primary aldosteronism (PA) is a condition characterized by hypertension and hypokalemia and caused by autonomous hypersecretion of the mineralocorticoid aldosterone from the adrenal glands, which damages the cardiovascular and central nervous …

12.11.2022 | Original Article

Prognostic value of textural features obtained from F-fluorodeoxyglucose (F-18 FDG) positron emission tomography/computed tomography (PET/CT) in patients with locally advanced cervical cancer undergoing concurrent chemoradiotherapy

Cervical cancer is one of the most common cancers among women with over 500,000 new cases annually worldwide, resulting in over 270,000 deaths [ 1 ]. A significant proportion of patients are diagnosed at a locally advanced stage [ 2 ]. Concurrent …

10.11.2022 | Original Article

Comparison of 1-h with 3-h planar 99mTc-pyrophosphate scintigraphy in patients with suspected transthyretin cardiac amyloidosis using SPECT as a reference standard

Technetium-99m pyrophosphate (PYP) imaging has been increasingly used for the non-invasive diagnosis of transthyretin cardiac amyloidosis (ATTR-CA) [ 1 , 2 ]. The recent expert consensus recommendations for multimodal imaging in cardiac amyloidosis …

09.11.2022 | Original Article

Comparative evaluation of radionuclide therapy using 90Y and 177Lu

Radionuclide therapy is a potential cancer treatment using radiopharmaceuticals with cytotoxic radionuclides. Various molecules, including antibodies, peptides, and small molecules with high specificity and affinity for the target, have been used …

Über diese Zeitschrift

Annals of Nuclear Medicine is an official journal of the Japanese Society of Nuclear Medicine. It develops the appropriate application of radioactive substances and stable nuclides in the field of medicine.

The journal promotes the exchange of ideas and information and research in nuclear medicine and includes the medical application of radionuclides and related subjects. It presents original articles, short communications, reviews and letters to the editor.

Free Open Access Publication Program - Submit your paper to ANM for this privilege!

Open Access (OA) publication is a good way to expose your article to many readers in the world. ANM may offer authors with charge free OA publication for high-quality articles. Upon acceptance of articles, OA publication in this program is considered according to the recommendation from the editor who manages the particular manuscript, and the editor-in-chief makes a final decision. The authors are noticed in the letter of acceptance if their article is selected for this offer.

Metadaten
Titel
Annals of Nuclear Medicine
Abdeckung
Volume 11/1997 - Volume 36/2022
Verlag
Springer Nature Singapore
Elektronische ISSN
1864-6433
Print ISSN
0914-7187
Zeitschriften-ID
12149
DOI
https://doi.org/10.1007/12149.1864-6433